• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ERIKA DE REYNOSA, S.A. DE C.V. CUSTOM COMBI SET; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ERIKA DE REYNOSA, S.A. DE C.V. CUSTOM COMBI SET; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE Back to Search Results
Catalog Number 03-2722-9
Device Problem Fluid/Blood Leak (1250)
Patient Problems Headache (1880); Low Blood Pressure/ Hypotension (1914); Dizziness (2194); Blood Loss (2597)
Event Date 01/08/2019
Event Type  Injury  
Manufacturer Narrative
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.  clinical investigation: a temporal relationship exists between hd therapy utilizing the custom combi set and the patient¿s adverse event(s) of headache, lightheadedness, blood loss and hypotension warranting observation in the er.The cause of the event(s) was a direct result of the patient¿s venous bloodline separating from the venous fistula needle (not a fresenius product).The cause of the disconnection is unknown; therefore, causality cannot be determined.Catheter/bloodline separation is uncommon; however, these event(s) can result in serious injury, significant blood loss and even death.Access lines should always remain visible to enable the detection of possible blood leaks.Based on the information available, the custom combi set cannot be disassociated from the event.While there is no documentation of any defect(s) at the connection site, samples were not retained following the event(s) nor was the connection visible for inspection during treatment.Therefore, no manufacturer investigation/evaluation can be made of the suspect product(s).Should additional information become available, the clinical investigation will be amended appropriately.
 
Event Description
It was reported that a hemodialysis (hd) patient experienced a disconnection between the fistula needle and bloodlines during their treatment, resulting in blood loss, lightheadedness, and hypotension.The patient arrived at the user facility for scheduled hd treatment alert and oriented.The patient¿s pre-dialysis vital signs were as follows: blood pressure 184/107, pulse 77, respiration 18, temperature 97.5.Hd treatment was initiated at 5:11am.At 6:55am, the patient stated that they had a headache and was lightheaded.The patient requested acetaminophen; their blood pressure was 66/38 and pulse was 69.The fresenius 2008t hd machine alarmed.The patient¿s fistula was covered with a blanket at this time and when the blanket was removed, it was noted that the venous blood line was disconnected from the venous fistula needle (not a fresenius product) line.The patient¿s estimated blood loss was 600-800ml; blood was noted on the floor, blanket, pillow, and the patient¿s shirt.Blood from the extracorporeal circuit was returned to the patient.Oxygen and 1000ml normal saline was administered, and emergency medical services (ems) was called.At 7:00am, the patient¿s blood pressure was 73/35 and pulse was 69.The patient stated that they felt better.At 7:09am, the patient¿s blood pressure was 121/64 and pulse was 64.Ems arrived at 7:10am and transported the patient to the hospital, where they were observed for several hours and then discharged home.The patient returned to their next scheduled dialysis treatment on (b)(6) 2019.Upon follow up, the clinical manager reported that the patient had to be reminded multiple times during treatment to refrain from moving their arm, although this cannot be confirmed as the root cause of the disconnection.The clinical manager confirmed that there were no loose connections, damage, or defects noted with any of the equipment or products involved in the events.It was confirmed that there were no changes in pressure noted that could have contributed to the reported event.It was confirmed that although acetaminophen was requested by the patient during treatment, the medication was not provided by the nurse.The patient was not admitted to the hospital, but was observed in the emergency room (er) with a heart rate monitor and oxygen administration.As a result of the event, the patient's erythropoiesis-stimulating agent was adjusted per the physician¿s orders.The patient's discharge summary was requested, but was not furnished.The manufacturers of the concomitant products have been notified of the reported event.
 
Manufacturer Narrative
Plant investigation: as the device was not returned to the manufacturer, a physical evaluation could not be performed.A batch records review was conducted by the manufacturer for the reported lot.There were no non-conformances or abnormalities identified during the manufacturing process which could be associated with the reported event.The entire lot has been sold and distributed.In addition, a device history review was performed and confirmed that the results of the in-progress and final quality control (qc) testing met all requirements.The lot met all specifications for release.A product history review did not reveal a probable cause for the customer complaint.As a physical evaluation could not be performed, a definitive conclusion regarding the reported incident could not be reached and a cause could not be confirmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CUSTOM COMBI SET
Type of Device
SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE
Manufacturer (Section D)
ERIKA DE REYNOSA, S.A. DE C.V.
mike allen #1331
parque industrial reynosa
reynosa 88780
MX  88780
MDR Report Key8277393
MDR Text Key134086573
Report Number8030665-2019-00186
Device Sequence Number1
Product Code FJK
UDI-Device Identifier00840861100293
UDI-Public00840861100293
Combination Product (y/n)N
PMA/PMN Number
K962081
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 02/07/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/25/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2021
Device Catalogue Number03-2722-9
Device Lot Number18LR01301
Was Device Available for Evaluation? No
Device Age MO
Date Manufacturer Received02/06/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age53 YR
Patient Weight49
-
-